Blood Platelets Market Analysis

  • Report ID: 4719
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Blood Platelets Market Analysis

Blood Platelets Segmentation 

Application (Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication)

The platelet function disorder segment is assumed to dominate the blood platelets market with a revenue of 51% by the end of 2036. The growth of this market is majorly driven by the growing prevalence of cancer among the population. Chronic myelogenous leukemia and various myeloma cancers result in the development of acquired platelet dysfunction in some cancer patients. Therefore, cancer patients often have to receive platelet transfusions. In addition, chronic platelet dysfunction increases the need for platelet transfusions. The incidence of myeloma in the UK is projected to increase by 11% between 2014 and 2036, reported as by Cancer Research UK Statistics 2021. These figures indicate an increasing demand for platelet transfusions in the treatment of cancer patients. Therefore, platelets are often given to such patients to reduce the need for red blood cells, surgical blood loss, and complications such as reoperation due to bleeding. 

End Users (Hospitals, Ambulatory Surgical Centers)

The hospital segment is predicted to witness the largest share of 72% during the time period between 2023 – 2036. The expansion of the segment can be attributed on the back of the accessibility of talented experts in the hospitals. The blood platelets market is expanding as a result of an increase in hospital admissions for patients with cancer, hemophilia, and other severe platelet disorders. Furthermore, higher accessibility of blood parts in hospitals brings about expanded use of blood platelets, bringing about expanded reception. Also, blood platelets are in high demand in hospitals as a result of an increase in the number of surgeries and severe injuries that necessitate blood transfusions. Additionally, promotive reimbursement policies have resulted in high demand for blood platelets in the hospital segment.

Our in-depth analysis of the global market includes the following segments:

           Application

  • Platelet Function Disorder
  • Hemophilia
  • Thrombocytopenia
  • Perioperative Indication

           Platelets

  • Whole Blood Derived Platelets
  • Apheresis Derived Platelets

           End User

  • Hospitals
  • Ambulatory Surgical Centers
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4719
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of blood platelets is assessed at USD 5.57 Billion.

The blood platelets market size was over USD 5.39 Billion in 2023 and is likely to reach USD 8.65 Billion by the end of 2036, growing at around 3.7% CAGR during the forecast period i.e., between 2024-2036. The increasing prevalence of blood-related disease and the increasing geriatric population is estimated to boost the market growth.

North America region is predicted to hold at 35% of the revenue share by 2036, driven by increased demand for blood transfusion along with rising number of accidents in the region.

Aggredyne Inc., Sysmex Corporation, Haemochrom Diagnostics GmbH, Eurobio Scientific, LABiTec Labor BioMedical Technologies GmbH, Thermo Fisher Scientific Inc., PerkinElimer Inc., Werfen, S.A., F. Hoffmann-La Roche Ltd., Terumo Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample